National Heart, Lung, and Blood Institute; Notice of Closed Meeting

---
identifier: "/us/fr/02-22470"
source: "fr"
legal_status: "authoritative_unofficial"
title: "National Heart, Lung, and Blood Institute; Notice of Closed Meeting"
title_number: 0
title_name: "Federal Register"
section_number: "02-22470"
section_name: "National Heart, Lung, and Blood Institute; Notice of Closed Meeting"
positive_law: false
currency: "2002-09-04"
last_updated: "2002-09-04"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "02-22470"
document_type: "notice"
publication_date: "2002-09-04"
agencies:
  - "Health and Human Services Department"
  - "National Institutes of Health"
fr_citation: "67 FR 56574"
fr_volume: 67
---


#  National Heart, Lung, and Blood Institute; Notice of Closed Meeting

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:* Clinical Trials Review Committee.

*Date:* October 28-29, 2002.

*Time:* 7 a.m. to 5 p.m.

*Agenda:* To review and evaluate grant applications.

*Place:* Hilton Silver Spring, 8727 Colesville Road, Silver Spring, MD 20910.

*Contact Person:* Valerie L. Prenger, PhD, Health Scientist Administrator, Review Branch, Room 7194, Division of Extramural Affairs, National Heart, Lung, and Blood Institute, National Institutes of Health, 6701 Rockledge Drive, MSC 7924, Bethesda, MD 20892-7924, (301) 435-0288, *[email protected].*

(Catalogue of Federal Domestic Assistance Program Nos. 93.233, National Center for Sleep Disorders Research; 93.837, Heart and Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, Blood Diseases and Resources Research, National Institutes of Health, HHS)

Dated: August 27, 2002.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory Committee Policy.